| Title | Guidance: Diabetes Mellitus: Efficacy Endpoints for Clinical Trials Investigating Antidiabetic Drugs and Biological Products |
| ToC Doc | Diabetes Mellitus: Efficacy Endpoints for Clinical Trials Investigating Antidiabetic Drugs and Biological Products |
| Docket Number | 2023-11321 |
| Type | Notice |
| Subject | Guidance: Diabetes Mellitus: Efficacy Endpoints for Clinical Trials Investigating Antidiabetic Drugs and Biological Products |
| Publication Date | 2023-05-26 |
| Last Updated Date | 2023-05-25 08:15:10 -0400 |
| Last Public Inspection | 2023-05-25 |
| Filed At | 2023-05-25T08:45:00.000-04:00 |
| 2023-11321_PI.pdf (105214 bytes) | |
| Download | TXT / HTML / JSON |
| Number of Pages | 5 |
| Filing Type | regular |
| Agencies | Food and Drug Administration |
You can find the raw source document below...